Using 20% albumin with Ringer's lactate during cytoreductive surgery and HIPEC.
Official title: Evaluation de l'efficacité du Remplissage Vasculaire Par de l'ALBUmine Humaine 20% + Ringer Lactate comparé au Ringer Lactate Seul Chez Les Patients opérés Par cytoréduction Avec CHimiothérapie Intrapéritonéale hyPerthermique
Run by Assistance Publique - Hôpitaux de Paris · NCT06351475 · Data updated 2026-11-12
This study will test whether adding 20% albumin to Ringer's lactate during cytoreductive surgery with HIPEC for adults with peritoneal carcinomatosis reduces the need for crystalloid fluids and improves postoperative outcomes.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years to 80 Years |
| Sex | All |
| Enrollment | 140 (estimated) |
| Sponsor | Assistance Publique - Hôpitaux de Paris Academic / other |
| Drugs / interventions | chemotherapy |
| Locations | 8 sites (Lyon and 7 other locations) |
| Status | Recruiting |
| Started | September 3, 2025 |
| Main results expected | October 2027 |
| Study ends | October 2027 |
| Registry record updated | September 29, 2026 |
| Trial ID | NCT06351475 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults aged 18–75 with peritoneal carcinomatosis scheduled for cytoreductive surgery with HIPEC who are medically fit for major surgery and do not have conditions that affect albumin levels are the ideal candidates.
✕Probably not a fit
Patients over 75, those with severe hypoalbuminemia, liver cirrhosis, nephrotic syndrome, significant cardiac or pulmonary disease, or large symptomatic ascites are unlikely to benefit or are excluded from participation.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This interventional trial compares intraoperative administration of concentrated 20% albumin combined with Ringer's lactate versus Ringer's lactate alone during cytoreductive surgery with HIPEC. The albumin arm is intended to reduce the total crystalloid volume given during the procedure, and perioperative fluid balance and postoperative complications will be recorded. Eligible adults (18–75) planned for CRS with HIPEC and affiliated with French health insurance will be enrolled, while patients with severe hypoalbuminemia, significant liver or kidney disease, reduced cardiac function, or high pulmonary risk are excluded. The protocol is carried out at participating centers in Paris and Montpellier.
Why it matters
Potential benefit: If successful, adding 20% albumin could lower crystalloid requirements and reduce fluid-related postoperative complications after CRS with HIPEC.
How similar studies have gone: Albumin has been widely studied in critically ill patients with mixed results, while intraoperative use during major oncologic procedures like CRS with HIPEC has not been well tested.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Male and female patients aged 18 years old and older * Planned cytoreductive surgery with HIPEC for peritoneal carcinomatosis (from gynaecological or digestive origin) * Patient volunteer for the study and provided written informed consent * Patient affiliated to the French Health Insurance Exclusion Criteria: * Adults \>75 years old * Functional status rendering the patient ineligible for cytoreduction with CHIP (ECOG \> 2 or Karnofsky index \< 75) * Pre-existing preoperative conditions affecting albuminemia (hepatic cirrhosis, nephrotic syndrome, exudative enteropathy, malnutrition) * Severe preoperative hypoalbuminemia (albuminemia \< 20 g/L) * History of chronic left heart failure with reduced left ventricular ejection fraction (left ventricular ejection fraction \< 40%) * Patients at high risk of perioperative and postoperative pulmonary complications (atelectasis, significant pleural effusions) * Significant ascites with preoperative respiratory repercussions * Uncontrolled diabetes (HbA1c \> 8.5%) * Allergy to exogenous human albumin and its excipients. * Contraindication to the administration of Ringer's lactate (history of allergy) * Hyperkalemia \> 6.0 mmol/L * Hypercalcemia (total calcium \> 2.60 mmol/L) * Chronic use of digitalis and hyperkalemic diuretics * Pregnancy, breastfeeding * Known preoperative renal failure (GFR \< 30 mL/min/1.73m2 or extrarenal purification) * Recent brain trauma \< 6 months (traumatic, ischemic, or hemorrhagic) * Participation in another interventional study involving human subjects or being in the exclusion period following a previous study involving human subjects, if applicable * Patient deprived of liberty * Patient under guardianship or curatorship
Where it's running
-
Hôpital Lyon Sud Pierre Bénite
Lyon, France Recruiting -
Institut régional du Cancer de Montpellier
Montpellier, France Recruiting -
La Pitié Salpetriere hospital
Paris, France Recruiting -
Lariboisière hospital
Paris, France Recruiting -
Saint Louis hospital
Paris, France Recruiting -
Robert Debré hospital
Reims, France Recruiting
Show 2 more locations
-
Hôpital Hautepierre / UIC ARMO
Strasbourg, France Recruiting -
Gustave Roussy Institute
Villejuif, France Recruiting
Study contacts
- Study coordinator: Arthur Moreau, Dr
- Email: arthur.moreau@aphp.fr
- Phone: 142499394
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Urine Output Monitoring to Guide Fluid and Diuretic Therapy in Cardiac ICU Patients
This observational study tests how continuous urine output data from the FIZE kUO device can help guide fluid therapy and diuretic use in adults after heart surgery.
-
Prehabilitation with Resistance, Aerobic, or Both Before Colorectal Surgery
Four pre-surgery exercise options (resistance, aerobic, both, or none) will be tested to see which best reduces complications after colorectal cancer surgery.
-
Axillary Web Syndrome after Breast Cancer Surgery: Incidence, Risk Factors, and Outcomes
This study tests how often AWS occurs after breast cancer surgery and what factors make it more likely, using a forward-looking approach in women undergoing SLNB or ALND.
-
Intraoperative Warmth and Moisture for VATS: Do Humidified Gases Help After Thoracic Surgery?
This observational study looks at whether using heated, humidified gases during VATS with one-lung ventilation helps reduce lung-related postoperative problems.
-
Predicting liver failure after major liver surgery using CT measurements and vascular shape changes
Doctors are testing whether adding vascular deformation mapping to CT measurements can better predict liver failure after removing a large portion of the liver.
-
Hernia Sac Flap Coverage of Mesh in Complex Bony-Edged Ventral Hernias
We’re testing whether using the patient’s own hernia sac as a living flap underneath the mesh helps healing after complex ventral hernia repair when part of the edge is bone.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.